EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Go back to EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL| Edwards Lifesciences (NYSE: EW) | Delayed: 87.30 +1.45 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.85 | 52 Week High | $166.87 | |||
| Open | $86.27 | 52 Week Low | $72.20 | |||
| Day High | $87.93 | P/E | 25.38 | |||
| Day Low | $85.97 | EPS | $3.44 | |||
| Volume | 2,197,839 | |||||
